Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed Astrocytoma, Grade IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT06973096
What this trial is testing

CART-EGFR-IL13Ra2 in Newly Diagnosed GBM Following Initial Radiotherapy

Who this might be right for
Glioblastoma
University of Pennsylvania 9
Not applicableLooking for participantsNCT07488754
What this trial is testing

Local, Targeted Therapy With Alpha Emitter [225Ac]Ac-DOTA-SP (TAT) In Newly Diagnosed Glioma (WHO G3-G4)

Who this might be right for
GlioblastomaHigh-Grade Glioma (WHO III-IV)Glioblastoma (GBM)
Medical University of Warsaw 35
Large-scale testing (Phase 3)Ended earlyNCT00615186
What this trial is testing

Glioblastoma Multiforme (GBM) Locoregional Agent Survival Study - Anti-tenascin Radiolabeled Antibody Therapy

Who this might be right for
Glioblastoma Multiforme
Bradmer Pharmaceuticals Inc. 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT04677049
What this trial is testing

Study of Niacin in Glioblastoma

Who this might be right for
Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype
AHS Cancer Control Alberta 59
Testing effectiveness (Phase 2)Study completedNCT00006355
What this trial is testing

Pyrazoloacridine Followed by Radiation Therapy in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Not applicableStudy completedNCT03278249
What this trial is testing

Feasibility Study of Modified Atkins Ketogenic Diet in the Treatment of Newly Diagnosed Malignant Glioma

Who this might be right for
Glioblastoma
University of Cincinnati 12
Large-scale testing (Phase 3)Active Not RecruitingNCT05095376
What this trial is testing

Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma

Who this might be right for
GlioblastomaGliosarcoma
NRG Oncology 265
Testing effectiveness (Phase 2)Study completedNCT00763750
What this trial is testing

PPX, Temozolomide, and Concurrent Radiation for Newly Diagnosed Brain Tumors

Who this might be right for
Brain Tumor
howard safran 25
Testing effectiveness (Phase 2)Study completedNCT00002752
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Cancers

Who this might be right for
Brain and Central Nervous System TumorsMetastatic Cancer
Duke University
Large-scale testing (Phase 3)UnknownNCT04536649
What this trial is testing

Proton and Heavy Ion Beam Radiation vs. Photon Beam Radiation for Newly Diagnosed Glioblastoma.

Who this might be right for
Glioblastoma
Shanghai Proton and Heavy Ion Center 369
Large-scale testing (Phase 3)Looking for participantsNCT03970447
What this trial is testing

A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma

Who this might be right for
Glioblastoma
Global Coalition for Adaptive Research 2,250
Early research (Phase 1)Study completedNCT03726515
What this trial is testing

CART-EGFRvIII + Pembrolizumab in GBM

Who this might be right for
Glioblastoma
University of Pennsylvania 7
Testing effectiveness (Phase 2)Study completedNCT00058097
What this trial is testing

Tipifarnib and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma
National Cancer Institute (NCI) 54
Early research (Phase 1)Ended earlyNCT02664363
What this trial is testing

EGFRvIII CAR T Cells for Newly-Diagnosed WHO Grade IV Malignant Glioma

Who this might be right for
GlioblastomaGliosarcoma
Daniel Landi 3
Testing effectiveness (Phase 2)Study completedNCT04119674
What this trial is testing

Pilot Study of Anlotinib With STUPP Regimen for Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
Zhejiang Cancer Hospital 33
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07789379
What this trial is testing

Adebrelimab Plus Temozolomide ± Hyperbaric Oxygen for Primary Glioblastoma

Who this might be right for
Glioblastoma
Wei Jiang 94
Testing effectiveness (Phase 2)Ended earlyNCT03018288
What this trial is testing

Radiation Therapy Plus Temozolomide and Pembrolizumab With and Without HSPPC-96 in Newly Diagnosed Glioblastoma (GBM)

Who this might be right for
Glioblastoma
National Cancer Institute (NCI) 90
Testing effectiveness (Phase 2)Ended earlyNCT02085304
What this trial is testing

Tumor Resection and Gliadel® Wafers, Followed by Temodar® With Standard Radiation or GammaKnife® for New GBM

Who this might be right for
Glioblastoma
St. Joseph's Hospital and Medical Center, Phoenix 8
Early research (Phase 1)Study completedNCT02871843
What this trial is testing

RRx-001 + Radiation + Temozolomide In Newly Diagnosed Glioblastoma and Anaplastic Gliomas

Who this might be right for
GlioblastomaOligodendrogliomaAnaplastic Oligodendroglioma
EpicentRx, Inc. 19
Testing effectiveness (Phase 2)UnknownNCT03400917
What this trial is testing

Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Newly Diagnosed Glioblastoma

Who this might be right for
Newly Diagnosed Glioblastoma
Aivita Biomedical, Inc. 55
Next Page